A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

GV Scagliotti; E Smit; L Bosquee; M O'Brien; A Ardizzoni; P Zatloukal; W Eberhardt; M Smid-Geirnaerdt; Hendrik Bruin; S Dussenne; C Legrand; G Giaccone

doi:10.1016/j.lungcan.2005.05.012

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

GV Scagliotti, E Smit, L Bosquee, M O'Brien, A Ardizzoni, P Zatloukal, W Eberhardt, M Smid-Geirnaerdt, Hendrik Bruin, S Dussenne, C Legrand, G Giaccone

Radiology & Nuclear Medicine

Research output: Contribution to journal › Article › Academic › peer-review

42 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	91-96
Number of pages	6
Journal	Lung Cancer
Volume	50
Issue number	1
DOIs	https://doi.org/10.1016/j.lungcan.2005.05.012
Publication status	Published - 2005

Research programs

EMC NIHES-03-30-01

Access to Document

10.1016/j.lungcan.2005.05.012

http://hdl.handle.net/1765/61589

Cite this

@article{6ae296a6b87d403a9c42f51baa772af8,

title = "A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)",

author = "GV Scagliotti and E Smit and L Bosquee and M O'Brien and A Ardizzoni and P Zatloukal and W Eberhardt and M Smid-Geirnaerdt and Hendrik Bruin and S Dussenne and C Legrand and G Giaccone",

year = "2005",

doi = "10.1016/j.lungcan.2005.05.012",

language = "Undefined/Unknown",

volume = "50",

pages = "91--96",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

AU - Scagliotti, GV

AU - Smit, E

AU - Bosquee, L

AU - O'Brien, M

AU - Ardizzoni, A

AU - Zatloukal, P

AU - Eberhardt, W

AU - Smid-Geirnaerdt, M

AU - Bruin, Hendrik

AU - Dussenne, S

AU - Legrand, C

AU - Giaccone, G

PY - 2005

Y1 - 2005

U2 - 10.1016/j.lungcan.2005.05.012

DO - 10.1016/j.lungcan.2005.05.012

M3 - Article

C2 - 16019107

SN - 0169-5002

VL - 50

SP - 91

EP - 96

JO - Lung Cancer

JF - Lung Cancer

IS - 1

ER -